Neuberger Berman Group
PTCT icon

Neuberger Berman Group’s PTC Therapeutics PTCT Stock Holding History

Neuberger Berman Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$471K Sell
5,771
-115,778
-95% -$8.36M ﹤0.01% 1822
2026
Q1 		$8.28M Buy
121,549
+9,959
+9% +$705K 0.01% 862
2025
Q4 		$8.48M Buy
111,590
+107,983
+2,994% +$7.85M 0.01% 845
2025
Q3 		$221K Buy
+3,607
New +$188K ﹤0.01% 1871
2022
Q4 		– Sell
-16,364
Closed -$821K – 1855
2022
Q3 		$821K Buy
+16,364
New +$802K ﹤0.01% 1311
2021
Q2 		– Sell
-24,141
Closed -$1.14M – 1823
2021
Q1 		$1.14M Sell
24,141
-39,359
-62% -$2.34M ﹤0.01% 1288
2020
Q4 		$3.88M Hold
63,500
– – ﹤0.01% 975
2020
Q3 		$2.97M Buy
63,500
+2,500
+4% +$123K ﹤0.01% 979
2020
Q2 		$3.1M Buy
61,000
+6,000
+11% +$295K ﹤0.01% 912
2020
Q1 		$2.45M Hold
55,000
– – ﹤0.01% 900
2019
Q4 		$2.64M Buy
55,000
+3,800
+7% +$161K ﹤0.01% 968
2019
Q3 		$1.73M Buy
51,200
+5,300
+12% +$231K ﹤0.01% 1044
2019
Q2 		$2.07M Buy
45,900
+24,900
+119% +$983K ﹤0.01% 1025
2019
Q1 		$790K Buy
+21,000
New +$705K ﹤0.01% 1168
2016
Q1 		– Sell
-15,731
Closed -$510K – 1520
2015
Q4 		$510K Buy
+15,731
New +$463K ﹤0.01% 1272
2015
Q3 		– Sell
-13,213
Closed -$636K – 1572
2015
Q2 		$636K Sell
13,213
-8,517
-39% -$497K ﹤0.01% 1289
2015
Q1 		$1.32M Sell
21,730
-5,570
-20% -$340K ﹤0.01% 1162
2014
Q4 		$1.41M Buy
27,300
+6,400
+31% +$282K ﹤0.01% 1140
2014
Q3 		$919K Buy
+20,900
New +$654K ﹤0.01% 1267

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Neuberger Berman Group's PTCT Position: Q2 2026 in Review

Neuberger Berman Group reduced its PTC Therapeutics (PTCT) stake by 95% in Q2 2026, selling an estimated $8.36M and leaving 5,771 shares worth $471K. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

Neuberger Berman Group first reported a position in PTCT in Q3 2014 and has held it in 19 quarters since. The position peaked at $8.48M in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Neuberger Berman Group held 5,771 shares of PTC Therapeutics worth $471K as of Q2 2026.
  • Neuberger Berman Group sold 115,778 PTC Therapeutics shares in Q2 2026, an estimated $8.36M.
  • PTC Therapeutics made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1822 holding.
  • Neuberger Berman Group first reported a position in PTC Therapeutics in Q3 2014 and has held it in 19 quarters since.
  • Neuberger Berman Group's PTC Therapeutics position peaked at $8.48M in Q4 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.